Neil Cashman insider trades: ProMIS Neurosciences (PMN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Neil reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | PMN | ↑ Buy | 10,000 | $3.86 | $39K | Direct | Nov 3, 2026 (1d) |
| Feb 10, 2025 | PMN | ↑ Buy | 15,000 | $0.97 | $15K | By his spouse | Feb 12, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PMN insiders
Open-market trades in the last 12 months
About Neil Cashman's insider trades
Neil Cashman is Chief Scientific Officer at ProMIS Neurosciences (PMN). Since Feb 10, 2025, Neil has reported 2 open-market purchases worth $53K and no sales on SEC Form 4. In the last 12 months: 1 buy ($39K).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.